A critical advance in cancer study is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer suppressor protein is frequently disabled in many kinds of tumors, causing uncontrolled https://sociallawy.com/story12573211/vhh-fragments-restore-p53-a-potential-pathway-for-tumor-management